Archive — US — techcrunch
DNA testing company 23andMe files for bankruptcy protection, CEO resigns
23andMe has filed for Chapter 11 bankruptcy, initiating a court-supervised asset sale. CEO Anne Wojcicki has resigned to pursue an independent bid for the company. This decision comes after the firm faced financial struggles, including a 99% drop in market cap since going public and a major data breach affecting nearly 7 million customers.
Key points
- 23andMe filed for Chapter 11 bankruptcy to facilitate asset sale.
- CEO Anne Wojcicki resigned to become an independent bidder.
- Mark Jensen stated that this process aims to resolve operational and financial issues.
- The company experienced a market cap decline over 99% from a peak of $6 billion.
- A significant cyberattack in 2023 compromised customer data and led to a $30 million lawsuit settlement.
Why it matters
- The bankruptcy filing reflects broader trends in the biotechnology sector struggling with profitability post-IPO.
- Data privacy concerns have intensified following the cyberattack, highlighting vulnerabilities in the tech and health industries.
- Similar IT trends show increasing regulatory scrutiny and investor caution in genetic testing markets.
The bankruptcy of 23andMe underscores the complex challenges facing biotech firms in a rapidly evolving digital landscape, where financial stability and data security are critical to success.